EchoGo® Heart Failure vs Study Watch with Irregular Pulse Monitor (Home)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is an AI platform that analyzes existing echocardiograms to provide rapid diagnostic insights for HFpEF. In contrast, Tool B, the Study Watch, is a wearable device focused on unobtrusive physiological monitoring, including ECG and irregular pulse detection for conditions like AFib. While both fall under cardiology AI, they address different clinical needs: diagnosis from imaging versus remote physiological monitoring.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure (Tool A) is designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. The Verily Study Watch (Tool B) is a wearable device primarily for irregular pulse monitoring to detect atrial fibrillation (AFib) and collects other physiological data for clinical research and healthcare use.
EchoGou00ae Heart Failure (Tool A) integrates seamlessly by analyzing routine echo video clips and delivering insights within 20 minutes through automated structured reports via DICOM workflow to PACS. The Verily Study Watch (Tool B) is a prescription-only wearable device that patients use, with its collected physiological data processed through cloud-based analytics.
EchoGou00ae Heart Failure (Tool A) is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For the Verily Study Watch (Tool B), pricing is not publicly available as it is a prescription-only device intended for clinical research and healthcare use, not direct consumer sale.
EchoGou00ae Heart Failure (Tool A) analyzes routine echocardiogram video clips to derive its insights. The Verily Study Watch (Tool B) collects physiological data from multiple sensors, including on-demand single-channel ECG, heart rate, electrodermal activity, and inertial movements, along with environmental sensors.
EchoGou00ae Heart Failure (Tool A) is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection. The Verily Study Watch (Tool B) is designed for irregular pulse monitoring for atrial fibrillation (AFib) detection, but specific sensitivity and specificity metrics are not provided in the description.